美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Opexa Therapeutics Inc. Warrants

0.0876

-0.0022-2.45%

成交量：316.75万

成交额：27.75万

市值：- -

市盈率：- -

高：0.1035

开：0.1005

低：0.0800

收：0.0898

52周最高：0.3360

52周最低：0.0053

股本：- -

流通股本：- -

量比：- -

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Opexa Therapeutics Inc. Warrants

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

邮编：

- -

电话：

- -

传真：

- -

简介：

Opexa Therapeutics is a biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease.

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/OPXAW/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OPXAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPXAW\",,,,,undefined,":{"symbol":"OPXAW","market":"US","secType":"STK","nameCN":"Opexa Therapeutics Inc. Warrants","latestPrice":0.0876,"timestamp":1505937600000,"preClose":0.0898,"halted":0,"volume":3167481,"delay":0,"changeRate":-0.02449888641425398,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-0.0022,"latestTime":"03-18 11:07:07 EDT","open":0.1005,"high":0.1035,"low":0.08,"amount":277471.3356,"amplitude":0.261693,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773864000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.0898,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPXAW\",,,,,undefined,":{"symbol":"OPXAW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.1035,"amplitude":0.261693,"preClose":0.0898,"low":0.08,"week52Low":0.0053,"pbRate":"--","week52High":0.336,"institutionHeld":0,"latestPrice":0.0876,"eps":0,"divideRate":0,"volume":3167481,"delay":0,"open":0.1005,"prevYearClose":0.9071},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OPXAW\",params:#limit:5,,,undefined,":[{"date":"2017-09-21","symbol":"OPXAW","type":"split","dateTimestamp":1505966400000,"forFactor":10.355527,"toFactor":1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OPXAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OPXAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://","stockEarnings":[{"period":"1week","weight":-0.9034},{"period":"1month","weight":-0.9034},{"period":"3month","weight":-0.9034},{"period":"6month","weight":-0.9034},{"period":"1year","weight":-0.9034},{"period":"ytd","weight":-0.9034}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Opexa Therapeutics is a biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease.","exchange":"NASDAQ","name":"Opexa Therapeutics Inc. Warrants","nameEN":"Opexa Therapeutics, Inc. Warrants"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OPXAW\",market:\"US\",,,undefined,":null}}